Skip to main content
Erschienen in: Clinical Rheumatology 12/2013

01.12.2013 | Original Article

Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis

verfasst von: C. Ickinger, E. Musenge, M. Tikly

Erschienen in: Clinical Rheumatology | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to determine the pattern and predictors of joint damage measured by the rheumatoid arthritis articular damage (RAAD) score and to describe its relationship to functional disability in patients with established rheumatoid arthritis (RA). One hundred Black patients with RA of disease duration ≥5 years were studied cross-sectionally. Data collected included socio-demographics, disease duration, smoking, body mass index (BMI), extraarticular features, rheumatoid factor (RF), haemoglobin (Hb), disease activity (DAS28), delay in disease-modifying antirheumatic drug initiation (DMARD lag) and treatment history. As outcome measures, the RAAD score and modified Health Assessment Questionnaire (mHAQ-DI) were used to assess joint damage and disability, respectively. Data were analysed by univariate and multivariate analyses. The mean RAAD score was 28.2 ± 12.8 for a mean disease duration of 17.5 ± 8.5 years. The majority of patients still had active disease (mean DAS28 4.4) and severe disability (mean mHAQ-DI 1.9), reflected in part by a long mean DMARD lag (9 years). Wrist and ankle joints were commonly involved. Multivariate analysis revealed that longer disease duration, higher RF titres and lower BMI were significant independent predictors of a higher RAAD score. The mHAQ-DI was significantly associated with DAS28, RAAD, education and Hb. Our results provide support for aspects of validity of the RAAD score and for its use in under-resourced settings. Further longitudinal studies are needed to evaluate its sensitivity to change in monitoring joint damage. Patterns of joint involvement and the inverse relationship between BMI and joint damage also merit further investigation in Black RA patients.
Literatur
1.
Zurück zum Zitat Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J et al (2000) The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 39:122–32CrossRef Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J et al (2000) The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 39:122–32CrossRef
2.
Zurück zum Zitat Scott DL, Smith C, Kingsley G (2003) Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 21(Suppl 31):S20–7PubMed Scott DL, Smith C, Kingsley G (2003) Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 21(Suppl 31):S20–7PubMed
3.
Zurück zum Zitat Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D et al (2012) The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Ann Rheum Dis 71:836–44PubMedCrossRef Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D et al (2012) The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Ann Rheum Dis 71:836–44PubMedCrossRef
4.
Zurück zum Zitat Adebajo AO, Reid DM (1991) The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med 80:633–40PubMed Adebajo AO, Reid DM (1991) The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med 80:633–40PubMed
5.
Zurück zum Zitat Chikanza IC, Stein M, Lutalo S, Gibson T (1994) The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol 21:2011–5PubMed Chikanza IC, Stein M, Lutalo S, Gibson T (1994) The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol 21:2011–5PubMed
6.
Zurück zum Zitat Tikly M, Zannettou N, Hopley M (2003) A longitudinal study of rheumatoid arthritis in South Africans. Med Gen Med 5:2 Tikly M, Zannettou N, Hopley M (2003) A longitudinal study of rheumatoid arthritis in South Africans. Med Gen Med 5:2
7.
Zurück zum Zitat Solomon A, Christian BF, Dessein PH, Stanwix AE (2005) The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 35:122–31PubMedCrossRef Solomon A, Christian BF, Dessein PH, Stanwix AE (2005) The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 35:122–31PubMedCrossRef
8.
Zurück zum Zitat Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26:24–9PubMedCrossRef Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26:24–9PubMedCrossRef
9.
Zurück zum Zitat Maritz NG, Gerber AJ, Greyling SJ, Sandra BB (2005) A radiological study of the rheumatoid hand in black South Africans. SAMJ 95:795–7PubMed Maritz NG, Gerber AJ, Greyling SJ, Sandra BB (2005) A radiological study of the rheumatoid hand in black South Africans. SAMJ 95:795–7PubMed
10.
Zurück zum Zitat Zijlstra TR, Bernelot Moens HJ, Bukhari MA (2002) The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA. Ann Rheum Dis 61:20–3PubMedCrossRef Zijlstra TR, Bernelot Moens HJ, Bukhari MA (2002) The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA. Ann Rheum Dis 61:20–3PubMedCrossRef
11.
Zurück zum Zitat Bejia I, Braham R, Said M, Salem KB, Touzi M, Bergaoui N (2005) Reliability of the rheumatoid arthritis articular damage score in Tunisian patients. Clin Rheumatol 24:593–4PubMedCrossRef Bejia I, Braham R, Said M, Salem KB, Touzi M, Bergaoui N (2005) Reliability of the rheumatoid arthritis articular damage score in Tunisian patients. Clin Rheumatol 24:593–4PubMedCrossRef
12.
Zurück zum Zitat Eksioglu E, Tuncay R, Gurcay E, Bal A, Cakci A (2007) Articular damage in late rheumatoid arthritis. Clin Rheumatol 26:314–8PubMedCrossRef Eksioglu E, Tuncay R, Gurcay E, Bal A, Cakci A (2007) Articular damage in late rheumatoid arthritis. Clin Rheumatol 26:314–8PubMedCrossRef
13.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24PubMedCrossRef
14.
Zurück zum Zitat Kirwan JR, Reeback JS (1986) Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206–9PubMedCrossRef Kirwan JR, Reeback JS (1986) Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206–9PubMedCrossRef
15.
Zurück zum Zitat Emery P (2002) Evidence supporting the benefit of early intervention in rheumatoid arthritis. J Rheumatol 29(Suppl 66):3–8 Emery P (2002) Evidence supporting the benefit of early intervention in rheumatoid arthritis. J Rheumatol 29(Suppl 66):3–8
16.
Zurück zum Zitat Abu-Shakra M, Toker R, Flusser D, Flusser G, Friger M, Sukenik S et al (1998) Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 41:1190–5PubMedCrossRef Abu-Shakra M, Toker R, Flusser D, Flusser G, Friger M, Sukenik S et al (1998) Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 41:1190–5PubMedCrossRef
17.
Zurück zum Zitat Hernandez-Garcia C, Vargas E, Abasolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–8PubMed Hernandez-Garcia C, Vargas E, Abasolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–8PubMed
18.
Zurück zum Zitat Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M et al (2007) QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66:1491–6PubMedCrossRef Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M et al (2007) QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66:1491–6PubMedCrossRef
19.
Zurück zum Zitat Jamal S, Alibhai SM, Badley EM, Bombardier C (2011) Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 38:1282–8PubMedCrossRef Jamal S, Alibhai SM, Badley EM, Bombardier C (2011) Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 38:1282–8PubMedCrossRef
20.
Zurück zum Zitat Vliet Vlieland TP, Buitenhuis NA, Van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803–6PubMedCrossRef Vliet Vlieland TP, Buitenhuis NA, Van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803–6PubMedCrossRef
21.
Zurück zum Zitat Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G (2003) Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 30:2350–5PubMed Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G (2003) Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 30:2350–5PubMed
22.
Zurück zum Zitat Westhoff G, Rau R, Zink A (2007) Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 56:3575–82PubMedCrossRef Westhoff G, Rau R, Zink A (2007) Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 56:3575–82PubMedCrossRef
23.
Zurück zum Zitat Van Der Helm-Van Mil AH, Van Der Kooij SM, Allaart CF, Toes RE, Huizinga TW (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67:769–74PubMedCrossRef Van Der Helm-Van Mil AH, Van Der Kooij SM, Allaart CF, Toes RE, Huizinga TW (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67:769–74PubMedCrossRef
24.
Zurück zum Zitat Velpula UD, Agrawal S, Thomas J, Prabu VN, Rajasekhar L, Narsimulu G (2011) Low body mass index is adversely associated with radiographic joint damage in Indian patients with early rheumatoid arthritis. J Rheumatol 38:434–8PubMedCrossRef Velpula UD, Agrawal S, Thomas J, Prabu VN, Rajasekhar L, Narsimulu G (2011) Low body mass index is adversely associated with radiographic joint damage in Indian patients with early rheumatoid arthritis. J Rheumatol 38:434–8PubMedCrossRef
25.
Zurück zum Zitat Giles JT, Allison M, Bingham CO 3rd, Scott WM Jr, Bathon JM (2009) Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum 61:1248–56PubMedCrossRef Giles JT, Allison M, Bingham CO 3rd, Scott WM Jr, Bathon JM (2009) Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum 61:1248–56PubMedCrossRef
26.
Zurück zum Zitat Islander U, Jochems C, Lagerquist MK, Forsblad-D’elia H, Carlsten H (2011) Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol 335:14–29PubMedCrossRef Islander U, Jochems C, Lagerquist MK, Forsblad-D’elia H, Carlsten H (2011) Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol 335:14–29PubMedCrossRef
27.
Zurück zum Zitat Wolfe F, Sharp JT (1998) Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 41:1571–82PubMedCrossRef Wolfe F, Sharp JT (1998) Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 41:1571–82PubMedCrossRef
28.
Zurück zum Zitat Guillemin F, Gerard N, Van Leeuwen M, Smedstad LM, Kvien TK, Van Den Heuvel W (2003) Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumatol 30:2585–9PubMed Guillemin F, Gerard N, Van Leeuwen M, Smedstad LM, Kvien TK, Van Den Heuvel W (2003) Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumatol 30:2585–9PubMed
29.
Zurück zum Zitat Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196–201PubMedCrossRef Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196–201PubMedCrossRef
30.
Zurück zum Zitat Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P et al (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67:212–7PubMedCrossRef Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P et al (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67:212–7PubMedCrossRef
31.
Zurück zum Zitat Hodkinson B, Meyer PW, Musenge E, Ally MM, Wadee AA, Anderson R et al (2010) The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol 29:615–8PubMedCrossRef Hodkinson B, Meyer PW, Musenge E, Ally MM, Wadee AA, Anderson R et al (2010) The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol 29:615–8PubMedCrossRef
32.
Zurück zum Zitat Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ (2002) Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 46:906–12PubMedCrossRef Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ (2002) Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 46:906–12PubMedCrossRef
33.
Zurück zum Zitat Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731–6PubMedCrossRef Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731–6PubMedCrossRef
34.
Zurück zum Zitat Drossaers-Bakker KW, De Buck M, Van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM (1999) Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 42:1854–60PubMedCrossRef Drossaers-Bakker KW, De Buck M, Van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM (1999) Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 42:1854–60PubMedCrossRef
35.
Zurück zum Zitat Odegard S, Landewe R, Van Der Heijde D, Kvien TK, Mowinckel P, Uhlig T (2006) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 54:68–75PubMedCrossRef Odegard S, Landewe R, Van Der Heijde D, Kvien TK, Mowinckel P, Uhlig T (2006) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 54:68–75PubMedCrossRef
36.
Zurück zum Zitat Courvoisier N, Dougados M, Cantagrel A, Goupille P, Meyer O, Sibilia J et al (2008) Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Res Ther 10:R106PubMedCrossRef Courvoisier N, Dougados M, Cantagrel A, Goupille P, Meyer O, Sibilia J et al (2008) Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Res Ther 10:R106PubMedCrossRef
37.
Zurück zum Zitat Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ (1997) Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 24:1504–9PubMed Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ (1997) Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 24:1504–9PubMed
38.
Zurück zum Zitat Wolfe F, Michaud K (2006) Anemia and renal function in patients with rheumatoid arthritis. J Rheumatol 33:1516–22PubMed Wolfe F, Michaud K (2006) Anemia and renal function in patients with rheumatoid arthritis. J Rheumatol 33:1516–22PubMed
39.
Zurück zum Zitat Han C, Rahman MU, Doyle MK, Bathon JM, Smolen J, Kavanaugh A et al (2007) Association of anemia and physical disability among patients with rheumatoid arthritis. J Rheumatol 34:2177–82PubMed Han C, Rahman MU, Doyle MK, Bathon JM, Smolen J, Kavanaugh A et al (2007) Association of anemia and physical disability among patients with rheumatoid arthritis. J Rheumatol 34:2177–82PubMed
40.
Zurück zum Zitat Hodkinson B, Musenge E, Ally M, Meyer PW, Anderson R, Tikly M (2012) Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol 31:613–9PubMedCrossRef Hodkinson B, Musenge E, Ally M, Meyer PW, Anderson R, Tikly M (2012) Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol 31:613–9PubMedCrossRef
Metadaten
Titel
Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis
verfasst von
C. Ickinger
E. Musenge
M. Tikly
Publikationsdatum
01.12.2013
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2013
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2306-3

Weitere Artikel der Ausgabe 12/2013

Clinical Rheumatology 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.